---
schema_version: "secwatch.filing_event.v1"
accession: "0001581280-25-000006"
form_type: "8-K"
ticker: "TWST"
cik: "0001581280"
company_name: "Twist Bioscience Corp"
filed_at: "2025-08-04T23:59:59+00:00"
generated_at: "2026-05-17T21:27:14.924329+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Twist Bioscience reports record Q3 revenue $96.1M (+18% YoY); swings to GAAP net income $20.4M

## Summary
- Record revenue $96.1M, up 18% YoY; NGS revenue grew 27% to $55.3M.
- Gross margin improved to 53.4% from 43.3% YoY; net income $20.4M ($0.34/share) vs loss $85.6M.
- FY2025 revenue guidance raised to $374-376M; gross margin guidance raised to 50.5%-51%.
- Adjusted EBITDA loss narrowed to $(8.0)M from $(22.0)M; expect breakeven by end of FY2026.
- Added ~184 net new customers; shipped 237,000 genes, up 12% YoY.

## SEC filing metadata
- accession: 0001581280-25-000006
- form_type: 8-K
- ticker: TWST
- cik: 0001581280
- company_name: Twist Bioscience Corp
- filed_at: 2025-08-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1581280/000158128025000006/0001581280-25-000006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1581280/000158128025000006/twist-20250804.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001581280-25-000006
- JSON: https://secwatch.observer/filing/0001581280-25-000006.json
- Plain text: https://secwatch.observer/filing/0001581280-25-000006.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.